aXichem strengthens its position in the European market in signing agreement with Uriach, at a yearly value of 400 thousand Euro, for melatonin formulations for sleeping aid
aXichem AB (publ), a pioneer in the development and marketing of natural analogue industrial chemicals, is delighted to announce the signing of an exclusive agreement with Uriach , one of Europe's oldest and steadily growing pharmaceutical companies, regarding aXivite in the sleeping aid category of the dietary supplement market. Under the Supply and Research Agreement Uriach is granted exclusivity in a melatonin formulation with aXivite in the territories of Spain, Portugal, Germany, Austria, and Romania. To achieve this exclusivity